Navigation Links
Daiichi Sankyo's Once-Daily Edoxaban Meets Primary Efficacy Endpoint for Stroke Prevention and Superiority for the Principal Safety Endpoint Compared to Warfarin for Patients with Atrial Fibrillation in a Phase 3 Clinical Trial
Date:11/19/2013

p>Forward-looking statements

This press release contains forward-looking statements and information about future developments in the sector, and the legal and business conditions of DAIICHI SANKYO, Co. Ltd. Such forward-looking statements are uncertain and are subject at all times to the risks of change, particularly to the usual risks faced by a global pharmaceutical company, including the impact of the prices for products and raw materials, medication safety, changes in exchange rates, government regulations, employee relations, taxes, political instability and terrorism as well as the results of independent demands and governmental inquiries that affect the affairs of the company. All forward-looking statements contained in this release hold true as of the date of publication. They do not represent any guarantee of future performance. Actual events and developments could differ materially from the forward-looking statements that are explicitly expressed or implied in these statements. DAIICHI SANKYO, Co. Ltd. assume no responsibility for the updating of such forward-looking statements about future developments of the sector, legal and business conditions and the company.

References

1.        Ruff, C et al. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J 2010;160:635-41.

2.        Giugliano, RP et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013.

3.        Ball, J et al. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167:1807–24.

4.    &#
'/>"/>

SOURCE Daiichi Sankyo
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Daiichi Sankyos Once-Daily Edoxaban Shows Comparable Efficacy and Superiority for the Principal Safety Endpoint Compared to Warfarin in a Phase 3 Study for the Treatment of Symptomatic VTE and Prevention of its Recurrence
2. Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Councils Chairman of the Board
3. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
4. Daiichi Sankyo Completes Enrolment in Hokusai - VTE, investigating once-daily Edoxaban in the Largest Single Phase 3 Study for the Treatment and Prevention of Recurrence of VTE
5. Daiichi Sankyo, Inc. Receives FDA Approval to Package Product at New Facility in Bethlehem, PA
6. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
7. Upsher-Smith Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile Of Once-Daily USL255 (Extended-Release Topiramate)
8. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
9. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
10. Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149
11. Coherus Announces CHS-0214 (Proposed Etanercept Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Minolta, Inc. (Konica Minolta) ( Tokyo : ... Ltda., an X-ray system equipment manufacturer based in Minas ... healthcare sales company, Konica Minolta Healthcare do ... market investment and growth With ... healthcare technical advancements and efficiencies are required. Aging and ...
(Date:7/2/2015)... ALPINION MEDICAL SYSTEMS Co., Ltd., announced today ... Developed to enhance user experience and patient care in ... produces superb image quality. With advanced imaging technologies, this ... imaging, and shared service applications. Confidence at ... E-CUBE Series, the E-CUBE 15 EX provides advanced women,s ...
(Date:7/2/2015)... July 2, 2015   Wilson Therapeutics AB , ... Hans Schikan to its board of directors. The appointment ... Meeting on June 30. "We are delighted ... Jonas Hansson , CEO of Wilson Therapeutics. "Hans ... we look forward to his contributions to the Company." ...
Breaking Medicine Technology:Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2
(Date:7/2/2015)... , ... July 02, 2015 , ... ... software, announced today a new release of their flagship product, 3D Tooth Atlas, ... Human Dentition quiz section and new tutorial videos. This latest release of the ...
(Date:7/2/2015)... Kan. (PRWEB) , ... July 02, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... of the top executive search firms in the healthcare industry, B. E. Smith ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... status of the Gelatin Capsule manufacturers. The report is a valuable source of ... report depicts the global and Chinese market for the Gelatin Capsule industry including ...
(Date:7/2/2015)... ... 02, 2015 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that it has made two key appointments at its ... Manager at Catalent’s Schorndorf facility, which provides large scale, complex oral solid manufacturing ...
(Date:7/2/2015)... ... July 02, 2015 , ... Today, East Liverpool City Hospital announced ... at East Liverpool City Hospital (ELCH). Pam is currently the Chief Nursing Officer at ... of surgery. Pam holds a master’s degree in health care administration as well as ...
Breaking Medicine News(10 mins):Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 3
... and loses 20 pounds by flooding his body with ... and blood to reach ultimate goal of sublime healthLOS ... CEO/Founder of iZO Cleanze, a comprehensive full-body detox program ... it of toxins, reaches the halfway point of his ...
... in Development of ,Next Generation, Dietary Supplements and Functional ... appointed Dr. Rudi E. Moerck as President & Chief ... CEO duties for Dr. Moerck comes on the heels ... Parry (India) Ltd, Chennai, India) announced last November. In ...
... Early research in animals suggests it might be possible ... appear to prevent noise-induced hearing loss in lab animals, ... finding suggests that it may be possible to create ... hearing loss in humans. , Two studies found that ...
... of Life is excited to announce that the David ... "Golfers drinking VaNu report feeling a higher ... an improved sense of well-being," said David Leadbetter, owner ... to VaNu during a PGA event in late 2008, ...
... 19 Varian Medical,Systems (NYSE: VAR ) today ... Therapy System, which is designed to help doctors to improve,treatments ... doctors,can use higher doses of radiation to control and manage ... , "CE mark is an important ...
... Dentistry - San Diego County,s premiere dental practice (online ... program designed to promote whole-body health at its newest ... Most people despise the dentist - the chemical smells, ... causes many Americans to skip the dentist altogether. But ...
Cached Medicine News:Health News:CEO of iZO Cleanze Completes Day 50 of 100-Day Juice Cleanse 2Health News:Valensa International's Dr. Rudi E. Moerck Appointed CEO 2Health News:A Pill to Prevent Hearing Loss? 2Health News:World-Renowned Golf Instructor David Leadbetter Promotes VaNu 2Health News:Varian Medical Systems Has Received CE Mark for Proton Therapy System 2Health News:Discover Whole Body Wellness Through a Revolutionary - and Natural - Approach to Dental Care 2Health News:Discover Whole Body Wellness Through a Revolutionary - and Natural - Approach to Dental Care 3
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
... Motorized tilt, user programmable memory two ... control on both chair sides, solid ... base. Single button folding armrests and ... handle on both chair sides, ergonomically ...
... A practical, comfortable chair for ... seat height is adjustable from ... by use of an independent ... rotatable through 360 and incorporates ...
Medicine Products: